ProPharma Group, a leading provider of compliance services, has acquired The Weinberg Group.
LEARN MORE
ABOUT US
About the Weinberg Group
Our Expertise
Our Mission and Values
Meet Our Team
News and Events
Careers
CONTACT US
PROPHARMA GROUP SITE
Follow
202.833.8077
The World’s Leading FDA Consultants.
MEDICAL DEVICES
Device Meetings
Device Submissions
DRUGS & BIOTECH
Regulatory Strategy Consulting
FDA Meetings
Pre-IND Meeting
End of Phase 2 Meeting
Pre-NDA Meeting
FDA Advisory Committee Meeting
FDA Submissions
IND Submission
NDA Submissions: 505(b)(1) & 505(b)(2)
Orphan Drug Designation
Nonclinical Drug Development
Study Design, Placement, & Monitoring
Discovery Stage Assistance
Results Analysis & Design of Follow On Work
Regulatory Due Diligence
ANDA SUBMISSIONS
QUALITY & COMPLIANCE
Good Clinical Practice (GCP) Services
Good Manufacturing Practices (GMP) Services
Quality Systems & Quality Management
RESOURCES
Home
>
Your inquiry has been received
Your inquiry has been received
Thank you for reaching out to us. We will contact you within two business days.
While you wait, we thought you might enjoy viewing our
Resource Center
.
Contact us today to learn about how
The Weinberg Group can help you.
I HAVE SOME QUESTIONS...
▸
I'D LIKE TO GET STARTED...
▸
Rrecent Posts
view more
▸
July 22, 2019
FDA Finalizes Guidance Concerning Premarket Tobacco Product Applications for E-Cigarettes
July 11, 2019
Improvements Are Coming to the Inactive Ingredient Database (IID)
June 28, 2019
Gene and Cellular Therapies: Five Keys to Regulatory Success
